BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2024 9:30:48 AM | Browse: 52 | Download: 171
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 93983
Country China
Received
2024-03-09 10:48
Peer-Review Started
2024-03-09 10:48
To Make the First Decision
Return for Revision
2024-09-10 02:03
Revised
2024-09-20 05:47
Second Decision
2024-09-29 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-09-29 08:23
Articles in Press
2024-09-29 08:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-10-16 03:56
Publish the Manuscript Online
2024-12-12 09:30
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Hui Wan, Yu-Xin Zhang, Guan-Yue Shan, Jun-Ya Cheng, Duan-Rui Qiao, Yi-Ying Liu, Wen-Na Shi and Hai-Jun Li
ORCID
Author(s) ORCID Number
Guan-Yue Shan http://orcid.org/0000-0002-3380-9418
Duan-Rui Qiao http://orcid.org/0000-0001-6875-2143
Hai-Jun Li http://orcid.org/0000-0002-2515-3076
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of China No. 81970529
Natural Science Foundation of Jilin Province No. 20230508074RC
Natural Science Foundation of Jilin Province No. YDZJ202401218ZYTS
Corresponding Author Hai-Jun Li, MD, PhD, Associate Professor, Institute of Liver Diseases, Institute of Translational Medicine, The First Hospital of Jilin University, No. 71 Xinmin Street, Changchun 130061, Jilin Province, China. hjli2012@jlu.edu.cn
Key Words Hepatitis B virus; Hepatocellular carcinoma; Hepatitis B virus-DNA; Immune tolerance; Antiviral therapy
Core Tip Hepatocellular carcinoma (HCC) is the seventh most common cancer in the world and is usually associated with hepatitis B virus (HBV) infection. Radical resection and antiviral therapy are considered key clinical treatments for patients with HBV-related HCC. However, many patients have their HCC and HBV infection detected at the same time, so they receive remedial antiviral treatment beginning in the perioperative period, missing the opportunity for long-term preoperative antiviral therapy. Therefore, evaluating the clinical efficacy and relevant factors of perioperative remedial antiviral therapy will be valuable.
Publish Date 2024-12-12 09:30
Citation <p>Wan H, Zhang YX, Shan GY, Cheng JY, Qiao DR, Liu YY, Shi WN, Li HJ. Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma. <i>World J Gastrointest Oncol</i> 2025; 17(1): 93983</p>
URL https://www.wjgnet.com/1948-5204/full/v17/i1/93983.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i1.93983
Full Article (PDF) WJGO-17-93983-with-cover.pdf
Manuscript File 93983_Auto_Edited_033725.docx
Answering Reviewers 93983-answering-reviewers.pdf
Audio Core Tip 93983-audio.m4a
Conflict-of-Interest Disclosure Form 93983-conflict-of-interest-statement.pdf
Copyright License Agreement 93983-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 93983-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate 93983-non-native-speakers.pdf
Peer-review Report 93983-peer-reviews.pdf
Scientific Misconduct Check 93983-scientific-misconduct-check.png
Scientific Editor Work List 93983-scientific-editor-work-list.pdf
CrossCheck Report 93983-crosscheck-report.png
CrossCheck Report 93983-crosscheck-report.pdf